Insider Trading Activity

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Kiselak Tomas

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-09-16 Purchase(A)	2024-09-17 8:56 pm	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	300,000	$17	$5,100,000	1,929,806 (Indirect)	View
2024-09-16 Purchase	2024-09-16 8:54 pm	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	300,000	$17	$5,100,000	1,641,891 (Indirect)	View
2023-09-29 Purchase	2023-10-03 4:00 pm	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	24,670	$13.63	$336,252	1,928,503 (Indirect)	View
2023-09-26 Purchase	2023-09-28 5:09 pm	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	30,000	$13.15	$394,500	1,903,833 (Indirect)	View
2023-09-19 Purchase	2023-09-21 4:23 pm	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	30,000	$13.2	$396,000	1,873,833 (Indirect)	View
2023-09-12 Purchase	2023-09-13 9:17 pm	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	24,254	$11.2	$271,680	1,850,333 (Indirect)	View
2023-07-13 Purchase	2023-07-17 8:00 pm	Apogee Therapeutics Inc.	APGE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director	2,941,176	$17	$49,999,992	988,045 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-09-27 Other	2024-10-01 8:00 pm	N/A N/A	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Director	62,146	$0	2,762,837 (Indirect)	View
2024-09-12 Option Award(A)	2024-09-17 8:56 pm	N/A 2034-09-11	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	37,000	$0	1,929,806 (Indirect)	View
2024-09-16 Conversion(A)	2024-09-17 8:56 pm	N/A N/A	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	12,635,428	$0	1,929,806 (Indirect)	View
2024-09-12 Option Award	2024-09-16 8:54 pm	N/A 2034-09-11	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	37,000	$0	1,641,891 (Indirect)	View
2024-09-16 Conversion	2024-09-16 8:54 pm	N/A N/A	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	12,635,428	$0	1,641,891 (Indirect)	View
2024-09-11 Option Award	2024-09-13 4:55 pm	N/A N/A	Oruka Therapeutics Inc.	ORKA	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	275,000	$23	3,212,082 (Indirect)	View
2024-09-11 Option Award	2024-09-13 4:55 pm	N/A N/A	Oruka Therapeutics Inc.	ORKA	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	160	$23,000	3,212,082 (Indirect)	View
Ownership	2024-09-12 9:41 pm	N/A N/A	Zenas BioPharma Inc.	ZBIO	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	0	$0	1,592,806 (Indirect)	View
Ownership	2024-09-06 5:07 pm	N/A N/A	Oruka Therapeutics Inc.	ORKA	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest III L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	0	$0	19,662,752 (Indirect)	View
2024-06-26 Option Award	2024-06-28 4:05 pm	N/A 2034-06-26	Viridian Therapeutics Inc.	VRDN	Kiselak Tomas Director	21,000	$0	21,000 (Indirect)	View
2024-06-05 Option Award	2024-06-07 8:00 pm	N/A 2034-06-05	Apogee Therapeutics Inc.	APGE	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director	20,740	$0	20,740 (Direct)	View
2024-05-23 Option Award	2024-05-28 7:57 pm	N/A 2034-05-22	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Director	11,000	$0	11,000 (Indirect)	View
2024-05-14 Option Award	2024-05-16 4:10 pm	N/A 2034-05-14	Spyre Therapeutics Inc.	SYRE	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director	22,646	$0	22,646 (Indirect)	View
2024-04-25 Exercise	2024-04-25 4:55 pm	N/A N/A	Spyre Therapeutics Inc.	SYRE	Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	3,730,672	$0	5,176,222 (Indirect)	View
2024-04-01 Other	2024-04-01 6:21 pm	N/A N/A	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Director	58,857	$0	2,880,551 (Indirect)	View
2024-03-28 Other	2024-04-01 5:44 pm	N/A N/A	Apogee Therapeutics Inc.	APGE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director	498,765	$0	9,006,126 (Indirect)	View
2024-01-29 Other	2024-01-31 4:31 pm	N/A N/A	Apogee Therapeutics Inc.	APGE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director	943,695	$0	1,046,027 (Indirect)	View
2024-01-22 Option Award	2024-01-24 7:02 pm	N/A N/A	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	834,334	$12	3,595,170 (Indirect)	View
2024-01-22 Option Award	2024-01-24 7:02 pm	N/A N/A	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	832,333	$12	3,595,170 (Indirect)	View
2023-12-29 Other	2023-12-29 5:00 pm	N/A N/A	Spyre Therapeutics Inc.	SYRE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	3,841,518	$0	5,485,719 (Indirect)	View
2023-12-07 Option Award	2023-12-11 5:41 pm	N/A N/A	Spyre Therapeutics Inc.	SYRE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	16,667	$600	16,667 (Indirect)	View
2023-11-24 Conversion	2023-11-28 4:05 pm	N/A N/A	Spyre Therapeutics Inc.	AGLE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	3,521,367	$0	4,250,938 (Indirect)	View
2023-09-11 Option Award	2023-09-13 9:17 pm	N/A 2033-09-10	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	6,500	$0	1,850,333 (Indirect)	View
Ownership	2023-09-13 8:55 pm	N/A N/A	Dianthus Therapeutics Inc.	DNTH	Fairmount Funds Management LLC Kiselak Tomas Harwin Peter Evan Director 10% Owner	0	$0	1,819,579 (Indirect)	View
2023-07-13 Option Award	2023-07-17 8:00 pm	N/A 2033-07-13	Apogee Therapeutics Inc.	APGE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director	95,516	$0	988,045 (Direct)	View
Ownership	2023-06-30 5:32 pm	N/A N/A	Aeglea BioTherapeutics Inc.	AGLE	Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner	0	$0	536,284,540 (Indirect)	View
2023-06-14 Option Award	2023-06-16 7:54 pm	N/A 2033-06-14	Viridian Therapeutics Inc.	VRDN	Kiselak Tomas Director	20,000	$0	20,000 (Indirect)	View
2022-06-08 Option Award	2022-06-10 07:30 am	N/A 2032-06-08	Viridian Therapeutics Inc.	VRDN	Kiselak Tomas Director	12,500	$0	12,500 (Indirect)	View
2021-06-03 Option Award	2021-06-16 6:34 pm	N/A 2031-06-03	Viridian Therapeutics Inc.	VRDN	Kiselak Tomas Director	12,500	$0	12,500 (Direct)	View
2021-02-04 Option Award	2021-02-08 5:40 pm	N/A 2031-02-04	Viridian Therapeutics Inc.	VRDN	Kiselak Tomas Director	25,000	$0	25,000 (Direct)	View
2020-10-27 Option Award	2020-10-29 5:16 pm	N/A 2030-10-26	MIRAGEN THERAPEUTICS INC.	MGEN	Kiselak Tomas Director	24,000	$0	24,000 (Direct)	View

(A) Indicate amendment filing.

Insider Trading & Ownership - Kiselak Tomas